Innovating Works

H2020

Cerrada
HORIZON-EIC-2022-TRANSITIONOPEN-01
EIC Transition Open 2022
Expected Impact:At the end of the EIC Transition project, it should be ready for the next stage, which can be to apply for EIC Accelerator (if you are a SME, including start-ups or spin-offs), to seek other investors or sources of funding, to enter licensing or collaboration agreements with third parties, or other routes to market deployment. In case the project is not led by an SME or commercial partner, the formation and spin out of a new company can be included as part of the activities. It will be expected to describe the intended pathway and route to market in the proposal, and to specify milestones and KPIs during the implementation of your project to assess progress towards the market.
Sólo fondo perdido 100%
Europeo
Mostrando 261 al 280 de 328 resultados
HCAI4ALL: Human-Centric AI platform for heALth and Life sciences ABZU APS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Abzu ApS – an EU-based deep-tech start-up – is redefining the AI landscape with an explainable, accurate and scalable solution – the QLattic...
2022-11-16 - 2024-12-31 | Financiado
InDx CMC Implant: The InDx CMC Implant. A new treatment for thumb base joint arthritis. LOCI ORTHOPAEDICS LIMITED tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 The InDx CMC Implant is for the treatment of thumb base joint arthritis. It is the first evidence-based, surgeon-led innovation, implant sol...
2022-11-16 - 2024-04-30 | Financiado
SPHUN: Smart PHotonic devices Using Novel metamaterials ALCYON PHOTONICS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Alcyon Photonics, founded in 2018 as a spin-off of the National Research Council in Spain, provides high performance components to foster a...
2022-11-16 - 2025-05-31 | Financiado
DOWN-AUTONOMY: LCTB-21: A DYRK1A protein kinase inhibitor for treatment of cognitive decline in Down Syndrome. PERHA PHARMACEUTICALS SAS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 All people with Down Syndrome (DS) suffer from a certain level of impaired learning and memory (cognitive disorders) from childhood onwards,...
2022-11-16 - 2026-06-30 | Financiado
iBEMS-SeLiBat: Integrated Battery and Energy Management System for Second-Life Battery energy storage OCTAVE tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Octave’s product consists of a second-life battery energy storage system equipped with Octave’s cutting-edge battery and energy management t...
2022-11-15 - 2025-04-30 | Financiado
Dronamics: The first European cargo drone airline DRONAMICS LTD tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Dronamics is the first drone system for fuel-efficient, same-day, cross-border & long-haul middle-mile cargo deliveries. We will operate a p...
2022-11-14 - 2024-07-31 | Financiado
QruiseOS: Accelerating Quantum Technology Development with Machine Learning QRUISE GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 The field of quantum technologies encompasses a wide range of very different devices whichThe field of quantum technologies encompasses a wi...
2022-11-11 - 2024-12-31 | Financiado
TRIO++: The First Miniaturized 
Non-Resonant Antenna Tailored to 
Internet of Things Applications FRACTUS ANTENNAS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Our solution is a novel antenna technology (called ‘Virtual Antenna’) that our company has invented and patented (40+ patents granted). Due...
2022-11-11 - 2024-11-30 | Financiado
SBMP-microcarrier: SBMP - disrupting the manufacturing of biological drugs through a ground-breaking nanotechnology-bas... CELLEVATE AB tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Cellevate proposes a completely novel type of nanofibrous microcarriers for adherent cell culture in bioreactors based on the proprietary Su...
2022-11-11 - 2024-09-30 | Financiado
I-CREATE: Fighting cancer with next generation oncolytic immunotherapy in ovarian, head & neck, and lung cance... TILT BIOTHERAPEUTICS OY tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 TILT Biotherapeutics is a clinical-stage biotechnology company developing novel gene therapies for cancer. TILT’s lead asset, TILT-123, is a...
2022-11-11 - 2023-12-31 | Financiado
ACTIVE: Articular Cartilage Treatment with Injectable hydrogel is Valuable and long-term Effective HY2CARE BV tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Hy2Care brings a regenerative Injectable Hydrogel, of joint- and cartilage-mimicking composition, that is used to treat damaged cartilage. T...
2022-11-11 - 2024-09-30 | Financiado
AcouSome: Acoustofluidic thin-film actuated chip for exosome separation from blood ACOUSORT AB tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 AcouSome is a consortium stemming from the ongoing EIC-FET Open BioWings project, and consists of four of the BioWings project partners (Aco...
2022-11-11 - 2025-12-31 | Financiado
SEALENCE: Sub Sea Quieter, a disruptive, low cost and highly efficient Noise Mitigation System for reducing MR... GREENOVITES tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 For offshore windfarms or coastal foundations, pile driving technique is often used. But it generates a high level of noise, which severly d...
2022-11-10 - 2024-12-31 | Financiado
CARBONCAPS: CARBONCAPS - Efficient and verifiable carbon removal with ecosystem co-benefits. CARBO CULTURE OY tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 We have developed a patent protected, innovative, ‘Flash Carbonisation’ pyrolysis technology for the production of biochar, a stable form of...
2022-11-10 - 2024-09-30 | Financiado
Qu&Co-Flow: Quantum software platform for multiphysics simulations Pasqal Netherlands BV tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 This project will develop Qu&Co-Flow: the world’s first hybrid Quantum/AI software platform for multiphysics simulations. Qu&Co-Flow integra...
2022-11-03 - 2024-11-30 | Financiado
SCOLED: Strong-coupling-enhanced nanoparticle array organic light emitting diode AALTO KORKEAKOULUSAATIO SR tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 We propose a radical new solution to the problem of increasing the efficiency of organic light-emitting diodes (OLEDs) based on modifying th...
2022-11-02 - 2026-04-30 | Financiado
Nuventura: Novel dry air switchgear technology to reduce industry’s dependence on SF6 NUVENTURA GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Nuventura develops medium voltage (MV) gas insulated switchgear (GIS) which replaces SF6 - the world's strongest greenhouse gas - with dry a...
2022-11-01 - 2025-04-30 | Financiado
4for2: Breaking the Resolution Limit in Two-Photon Microscopy Using Negative Photochromism CHALMERS TEKNISKA HOGSKOLA AB tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Multiphoton microscopy is a benchmark tool in biomedical research, used for the fluorescence imaging in cellular environments. This has impo...
2022-11-01 - 2026-02-28 | Financiado
APAC-ON: APAC – the first targeted therapy for peripheral arterial occlusive disease. APLAGON OY tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 There is a major unmet need for effective and safe therapies for advanced peripheral arterial occlusive disease (PAOD) due to the high cardi...
2022-10-28 - 2025-02-28 | Financiado
VR4NEURO: Building the world’s largest digital hospital for neurological challenges PEILI VISION OY tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Peili Vision was founded in 2015 based on a vision to help people rehabilitate after traumatic health events, such as stroke. By combining V...
2022-10-28 - 2024-10-31 | Financiado